Xiaoxin Hao
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Bone health and treatments
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Hematopoietic Stem Cell Transplantation 7
- Acute Myeloid Leukemia Research 4
- Oncology 9
- Cancer Cells and Metastasis 5
- Cancer Immunotherapy and Biomarkers 3
- Bone health and treatments 2
- Co-authors
- Junke Zheng (7 shared papers)Zhuo Yu (5 shared papers)Chiqi Chen (5 shared papers)Hao Gu (5 shared papers)Xiaoxiao He (3 shared papers)Xiang H.-F. Zhang (4 shared papers)Aaron M. Muscarella (1 shared paper)Ligen Liu (3 shared papers)
- Journals
- Journal of Clinical Investigation (5 papers)Cancer Discovery (2 papers)Cell (2 papers)Blood (1 paper)JCI Insight (1 paper)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Xiaoxin Hao
23 papers receiving 697 citations
Xiaoxin Hao's Hit Papers
Peers
Comparison fields: 5 of 59
- Oncology 233
- Hematology 116
- Cancer Research 97
- Immunology 84
- Molecular Biology 205
Countries citing papers authored by Xiaoxin Hao
This map shows the geographic impact of Xiaoxin Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxin Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxin Hao more than expected).
Fields of papers citing papers by Xiaoxin Hao
This network shows the impact of papers produced by Xiaoxin Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxin Hao. The network helps show where Xiaoxin Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoxin Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 192 | |
| 2 | 2018 | 61 | |
| 3 | 2018 | 55 | |
| 4 | 2018 | 54 | |
| 5 | 2023 | 48 | |
| 6 | Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer Hit paper breakdown → | 2025 | 45 |
| 7 | 2021 | 41 | |
| 8 | 2021 | 38 | |
| 9 | 2020 | 36 | |
| 10 | 2022 | 26 | |
| 11 | 2020 | 23 | |
| 12 | 2017 | 21 | |
| 13 | 2018 | 16 | |
| 14 | 2025 | 11 | |
| 15 | 2024 | 10 | |
| 16 | 2024 | 8 | |
| 17 | 2019 | 5 | |
| 18 | 2025 | 5 | |
| 19 | 2025 | 2 | |
| 20 | 2024 | 1 |
About Xiaoxin Hao
Xiaoxin Hao is a scholar working on Hematology, Oncology, Immunology, Cancer Research and Sensory Systems, having authored 24 papers that have together received 701 indexed citations. Recurring topics across this work include Immune cells in cancer (8 papers), Hematopoietic Stem Cell Transplantation (7 papers), Cancer Cells and Metastasis (5 papers), Acute Myeloid Leukemia Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Bone health and treatments (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Oncology (233 citations), Hematology (116 citations), Cancer Research (97 citations), Immunology (84 citations) and Molecular Biology (205 citations). Xiaoxin Hao has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Junke Zheng, Zhuo Yu, Chiqi Chen, Hao Gu, Xiaoxiao He, Xiang H.-F. Zhang, Aaron M. Muscarella, Ligen Liu, Sergio Aguirre and Bo O. Zhou. Their work appears in journals such as Journal of Clinical Investigation, Cancer Discovery, Cell, Blood and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.